Atópiás dermatitisz (ekcéma): vizsgálatok itt: Litvánia

1 trial · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

  Where

  Kaunas, Vilnius

  Életkor

  12 év and over

  People

  510 worldwide

  Run by

  Nektar Therapeutics

  See details and how to joinNCT07690371 · EU 2025-524925-42-00